Brief: Amneal And Shilpa Announce U.S. FDA Approval Of Boruzu™

Shilpa Medicare

05/09/2024 21:27

Sept 5 (Reuters) - Amneal Pharmaceuticals Inc  AMRX.O :
    * AMNEAL AND SHILPA ANNOUNCE U.S. FDA APPROVAL OF BORUZU™,
THE
FIRST READY-TO-USE VERSION OF BORTEZOMIB FOR SUBCUTANEOUS
ADMINISTRATION
    * AMNEAL PHARMACEUTICALS: BORUZU IS EXPECTED TO LAUNCH WITH
A
UNIQUE J-CODE IN Q2 OF 2025

Source text for Eikon:  ID:nBw7lsZTca 
Further company coverage:  AMRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))